Growing Medical Acceptance of Psychedelics – The Daily Dive feat Derek Welsh of Revive Therapeutics

For our final episode of The Daily Dive this week, host Cassandra Leah is joined by that of Derek Welsh of Revive Therapeutics (CSE: RVV), and founder of Psilocin Pharma Corp, a subsidiary of the company. Derek joins us to discuss his outlook on that of the psychedelics market as a whole, and discuss what Revive is working on from a psychedelics standpoint.

Psilocin Pharma, which was acquired by Revive Therapeutics earlier this year, is the psychedelic-focused arm of the company. The company has developed production solutions for the active compound psilocybin. The firm has developed six formulations to date, while owning a robust pipeline of ongoing research and development work within the psychedelics space.


FULL DISCLOSURE: Revive Therapeutics is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Revive Therapeutics on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

California Senate Votes to Decriminalize Psychedelics

California lawmakers have passed Senate Bill 58, a groundbreaking piece of legislation that decriminalizes the...

Saturday, September 9, 2023, 07:14:00 AM

Revive Therapeutics Continues With Phase 3 Clinical Trial For Bucillamine, To File For Emergency Use Authorization

Revive Therapeutics (CSE: RVV) issued an update to the market this morning related to its...

Wednesday, December 23, 2020, 09:48:31 AM

Revive Therapeutics, Pharmather Partner On Psilocybin Cancer Research

Revive Therapeutics (CSE: RVV) and Pharmather Inc (CSE: PHRM) this morning jointly announced a research...

Wednesday, November 18, 2020, 07:30:40 AM

Revive Therapeutics Provides Update On Current Psilocybin Programs

Revive Therapeutics (CSE: RVV) this morning provided a corporate update as it pertains to its...

Tuesday, August 10, 2021, 08:36:06 AM

Revive Therapeutics Partners With University of Health Sciences Antigua To Further Psychedelics Research

Revive Therapeutics (CSE: RVV) this morning announced that it has entered into a collaboration to...

Thursday, June 17, 2021, 08:45:27 AM